Literature DB >> 21049487

Akt1 deficiency in schizophrenia and impairment of hippocampal plasticity and function.

Darrick T Balu1, Gregory C Carlson, Konrad Talbot, Hala Kazi, Tiffany E Hill-Smith, Rachel M Easton, Morris J Birnbaum, Irwin Lucki.   

Abstract

Genetic studies have associated deficient function of the serine/threonine kinase Akt1 with schizophrenia. This disorder is associated with developmental, structural, and functional abnormalities of the hippocampus that could be traced to abnormal Akt1 function. To establish a closer connection between Akt1 and hippocampal function, mice with a selective deletion of Akt1 (Akt1(-/-) mice) were examined for physiological and behavioral outcomes dependent on the hippocampus and associated with schizophrenia. Genetic deletion of Akt1 was associated with both impaired proliferative capacity of adult-born hippocampal progenitors and hippocampal long-term potentiation, indicating deficient functions of this brain region associated with neuroplasticity. Moreover, Akt1(-/-) mice demonstrated impairments in contextual fear conditioning and recall of spatial learning, behaviors known to selectively involve the hippocampus. Akt1(-/-) mice also showed reduced prepulse inhibition of the acoustic startle response, a sensorimotor gating response that is perturbed in schizophrenia. Postmortem tissue samples from patients with schizophrenia showed significant reductions of phosphorylated Akt levels in hilar neurons of the dentate gyrus, the neurogenic zone of the hippocampus. Taken together, these results implicate the Akt1 isoform in regulating hippocampal neuroplasticity and cognition and in contributing to the etiology of schizophrenia.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21049487      PMCID: PMC3258343          DOI: 10.1002/hipo.20887

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  51 in total

Review 1.  Neurobiology of schizophrenia.

Authors:  Christopher A Ross; Russell L Margolis; Sarah A J Reading; Mikhail Pletnikov; Joseph T Coyle
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

2.  Ablation of hippocampal neurogenesis impairs contextual fear conditioning and synaptic plasticity in the dentate gyrus.

Authors:  Michael D Saxe; Fortunato Battaglia; Jing-Wen Wang; Gael Malleret; Denis J David; James E Monckton; A Denise R Garcia; Michael V Sofroniew; Eric R Kandel; Luca Santarelli; René Hen; Michael R Drew
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-06       Impact factor: 11.205

Review 3.  The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia.

Authors:  Hans O Kalkman
Journal:  Pharmacol Ther       Date:  2006-01-23       Impact factor: 12.310

4.  Inhibition of neurogenesis interferes with hippocampus-dependent memory function.

Authors:  Gordon Winocur; J Martin Wojtowicz; Melanie Sekeres; Jason S Snyder; Sabrina Wang
Journal:  Hippocampus       Date:  2006       Impact factor: 3.899

5.  Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synaptic plasticity and memory in the rat.

Authors:  Jennifer M Horwood; Franck Dufour; Serge Laroche; Sabrina Davis
Journal:  Eur J Neurosci       Date:  2006-06       Impact factor: 3.386

6.  Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.

Authors:  Masayuki Ide; Tetsuo Ohnishi; Miyuki Murayama; Izuru Matsumoto; Kazuo Yamada; Yoshimi Iwayama; Irina Dedova; Tomoko Toyota; Takashi Asada; Akihiko Takashima; Takeo Yoshikawa
Journal:  J Neurochem       Date:  2006-10       Impact factor: 5.372

7.  Impairment on the hippocampal-dependent virtual Morris water task in schizophrenia.

Authors:  Faith M Hanlon; Michael P Weisend; Derek A Hamilton; Aaron P Jones; Robert J Thoma; Mingxiong Huang; Kimberly Martin; Ronald A Yeo; Gregory A Miller; Jose M Cañive
Journal:  Schizophr Res       Date:  2006-07-14       Impact factor: 4.939

8.  Association of AKT1 haplotype with the risk of schizophrenia in Iranian population.

Authors:  Sepideh N Bajestan; Amir H Sabouri; Masayuki Nakamura; Hiroshi Takashima; Mohammad R Keikhaee; Fatemeh Behdani; Mohammad R Fayyazi; Mohammad R Sargolzaee; Mahboobeh N Bajestan; Zahra Sabouri; Esmaeil Khayami; Sima Haghighi; Susan B Hashemi; Nobutaka Eiraku; Hamid Tufani; Hossein Najmabadi; Kimiyoshi Arimura; Akira Sano; Mitsuhiro Osame
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-06-05       Impact factor: 3.568

9.  Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.

Authors:  Zhong Zhao; Hanna Ksiezak-Reding; Silvana Riggio; Vahram Haroutunian; Giulio M Pasinetti
Journal:  Schizophr Res       Date:  2006-04-11       Impact factor: 4.939

10.  Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning.

Authors:  Wen-Sung Lai; Bin Xu; Koen G C Westphal; Marta Paterlini; Berend Olivier; Paul Pavlidis; Maria Karayiorgou; Joseph A Gogos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

View more
  36 in total

Review 1.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

2.  Altered CREB Binding to Activity-Dependent Genes in Serine Racemase Deficient Mice, a Mouse Model of Schizophrenia.

Authors:  Darrick T Balu; Joseph T Coyle
Journal:  ACS Chem Neurosci       Date:  2017-11-27       Impact factor: 4.418

3.  Phosphorylation of AKT and abdominal aortic aneurysm formation.

Authors:  Abhijit Ghosh; Guanyi Lu; Gang Su; Brendan McEvoy; Omar Sadiq; Paul D DiMusto; Adriana Laser; John S Futchko; Peter K Henke; Jonathan L Eliason; Gilbert R Upchurch
Journal:  Am J Pathol       Date:  2014-01       Impact factor: 4.307

4.  Perceptual training strongly improves visual motion perception in schizophrenia.

Authors:  Daniel J Norton; Ryan K McBain; Dost Ongür; Yue Chen
Journal:  Brain Cogn       Date:  2011-08-26       Impact factor: 2.310

Review 5.  Frontier of epilepsy research - mTOR signaling pathway.

Authors:  Chang Hoon Cho
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

6.  Accessing Gene Expression in Treatment-Resistant Schizophrenia.

Authors:  Patricia N Moretti; Vanessa K Ota; Eduardo S Gouvea; Mariana Pedrini; Marcos L Santoro; Fernanda Talarico; Leticia M Spindola; Carolina Muniz Carvalho; Cristiano Noto; Gabriela Xavier; Elisa Brietzke; Ary Gadelha; Rodrigo Bressan; Jair Mari; Sintia Belangero
Journal:  Mol Neurobiol       Date:  2018-01-26       Impact factor: 5.590

7.  Electrophysiological and behavioral responses to ketamine in mice with reduced Akt1 expression.

Authors:  Robert E Featherstone; Valerie M Tatard-Leitman; Jimmy D Suh; Robert Lin; Irwin Lucki; Steven J Siegel
Journal:  Psychopharmacology (Berl)       Date:  2013-02-08       Impact factor: 4.530

8.  Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.

Authors:  Chijioke N Egbujo; Duncan Sinclair; Karin E Borgmann-Winter; Steven E Arnold; Bruce I Turetsky; Chang-Gyu Hahn
Journal:  Schizophr Res       Date:  2015-08-07       Impact factor: 4.939

9.  Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction.

Authors:  Darrick T Balu; Yan Li; Matthew D Puhl; Michael A Benneyworth; Alo C Basu; Shunsuke Takagi; Vadim Y Bolshakov; Joseph T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-31       Impact factor: 11.205

Review 10.  The NMDA Receptor and Schizophrenia: From Pathophysiology to Treatment.

Authors:  D T Balu
Journal:  Adv Pharmacol       Date:  2016-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.